L. Levandoski

1.7k total citations
10 papers, 441 citations indexed

About

L. Levandoski is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, L. Levandoski has authored 10 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Genetics and 2 papers in Surgery. Recurrent topics in L. Levandoski's work include Diabetes Management and Research (9 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (6 papers) and Diabetes Treatment and Management (4 papers). L. Levandoski is often cited by papers focused on Diabetes Management and Research (9 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (6 papers) and Diabetes Treatment and Management (4 papers). L. Levandoski collaborates with scholars based in United States and Australia. L. Levandoski's co-authors include Neil H. White, Julio V. Santiago, Philip E. Cryer, Donald A Skor, Dennis M. Bier, Ronald L. Gingerich, Karen Tordjman, Julio Santiago, Robert M. Carney and William L. Clarke and has published in prestigious journals such as New England Journal of Medicine, Diabetes Care and Diabetes.

In The Last Decade

L. Levandoski

9 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Levandoski United States 8 363 174 153 84 50 10 441
Larry D. Hall United States 6 291 0.8× 130 0.7× 72 0.5× 102 1.2× 156 3.1× 9 510
W. Besch Germany 10 166 0.5× 181 1.0× 100 0.7× 32 0.4× 59 1.2× 64 307
Scott A. Segel United States 3 299 0.8× 171 1.0× 137 0.9× 39 0.5× 37 0.7× 4 363
Donald A Skor United States 8 386 1.1× 189 1.1× 145 0.9× 133 1.6× 63 1.3× 8 483
J H Holcombe United States 9 235 0.6× 42 0.2× 65 0.4× 24 0.3× 180 3.6× 14 352
I. M. E. Wentholt Netherlands 11 561 1.5× 327 1.9× 268 1.8× 20 0.2× 52 1.0× 18 702
C Thiffault United States 6 128 0.4× 115 0.7× 41 0.3× 132 1.6× 96 1.9× 8 323
Karin Katz United States 7 107 0.3× 47 0.3× 33 0.2× 50 0.6× 76 1.5× 11 315
Andrea Näke Germany 11 238 0.7× 136 0.8× 188 1.2× 97 1.2× 57 1.1× 17 386
John Paul Lock United States 8 132 0.4× 45 0.3× 29 0.2× 24 0.3× 55 1.1× 15 197

Countries citing papers authored by L. Levandoski

Since Specialization
Citations

This map shows the geographic impact of L. Levandoski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Levandoski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Levandoski more than expected).

Fields of papers citing papers by L. Levandoski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Levandoski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Levandoski. The network helps show where L. Levandoski may publish in the future.

Co-authorship network of co-authors of L. Levandoski

This figure shows the co-authorship network connecting the top 25 collaborators of L. Levandoski. A scholar is included among the top collaborators of L. Levandoski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Levandoski. L. Levandoski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Levandoski, L. & Julio V. Santiago. (1997). Insulin-dependent diabetes mellitus in adults.. PubMed. 6. 418–30.
2.
Santiago, Julio V., L. Levandoski, Jeanne Bubb, & Neil H. White. (1994). Definitions, causes, and risk factors for hypoglycemia in insulin-dependent diabetes.. PubMed. 5. 406–12. 1 indexed citations
3.
Clarke, William L., Dorothy Becker, Daniel J. Cox, et al.. (1988). Evaluation of a new system for self blood glucose monitoring. Diabetes Research and Clinical Practice. 4(3). 209–213. 33 indexed citations
4.
Tordjman, Karen, et al.. (1987). Failure of Nocturnal Hypoglycemia to Cause Fasting Hyperglycemia in Patients with Insulin-Dependent Diabetes Mellitus. New England Journal of Medicine. 317(25). 1552–1559. 30 indexed citations
6.
White, Neil H., Ronald L. Gingerich, L. Levandoski, Philip E. Cryer, & Julio V. Santiago. (1985). Plasma Pancreatic Polypeptide Response to Insulin-induced Hypoglycemia as a Marker for Defective Glucose Counterregulation in Insulin-dependent Diabetes Mellitus. Diabetes. 34(9). 870–875. 41 indexed citations
7.
Levandoski, L., Neil H. White, & Julio V. Santiago. (1984). Localized skin reactions to insulin: insulin lipodystrophies and skin reactions to pumped subcutaneous insulin therapy.. PubMed. 5 Suppl 1. 6–10. 10 indexed citations
8.
Santiago, Julio V., Neil H. White, Donald A Skor, et al.. (1984). Defective glucose counterregulation limits intensive therapy of diabetes mellitus. American Journal of Physiology-Endocrinology and Metabolism. 247(2). E215–E220. 22 indexed citations
9.
Carney, Robert M., et al.. (1983). The Effects of Blood Glucose Testing Versus Urine Sugar Testing on the Metabolic Control of Insulin-Dependent Diabetic Children. Diabetes Care. 6(4). 378–380. 21 indexed citations
10.
White, Neil H., Donald A Skor, Philip E. Cryer, et al.. (1983). Identification of Type I Diabetic Patients at Increased Risk for Hypoglycemia during Intensive Therapy. New England Journal of Medicine. 308(9). 485–491. 276 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026